Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionChamplain Investment Partners, LLC
Latest Disclosed Ownership1,033,497 shares
Latest Disclosed Value $ 82,762,440
Champlain Investment Partners, LLC reports 40.41% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 13, 2026 - Champlain Investment Partners, LLC filed a 13F-HR form disclosing ownership of 1,033,497 shares of Edwards Lifesciences Corporation (MX:EW) valued at $82,762,440 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,734,212 shares of Edwards Lifesciences Corporation. This represents a change in shares of -40.41% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,033,497 -700,715 -40.41 82,762 -44.02 1.0502
2026-02-13 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,734,212 -380,325 -17.99 147,842 -10.10 1.4968
2025-11-12 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,114,537 -109,167 -4.91 164,448 -5.44 1.2401
2025-08-12 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,223,704 -388,085 -14.86 173,916 -8.13 1.2140
2025-05-14 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,611,789 -209,924 -7.44 189,302 -9.38 1.3712
2025-02-13 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,821,713 -258,990 -8.41 208,891 2.75 1.3217
2024-11-12 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,080,703 132,515 4.49 203,296 -25.35 1.2287
2024-08-14 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,948,188 -15,980 -0.54 272,324 -3.86 1.6696
2024-05-13 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,964,168 88,205 3.07 283,256 29.17 1.6220
2024-02-13 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,875,963 108,640 3.93 219,292 14.38 1.3002
2023-11-13 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,767,323 -3,170 -0.11 191,720 -26.64 1.2445
2023-08-11 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,770,493 6,840 0.25 261,341 14.30 1.6093
2023-05-12 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,763,653 -189,150 -6.41 228,637 3.78 1.4396
2023-02-13 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,952,803 -32,213 -1.08 220,309 -10.68 1.4131
2022-11-14 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,985,016 -63,930 -2.10 246,652 -14.93 1.6838
2022-08-12 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,048,946 -36,111 -1.17 289,924 -20.17 1.8738
2022-05-12 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,085,057 31,560 1.03 363,173 -8.19 1.8808
2022-02-10 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,053,497 -16,775 -0.55 395,581 13.81 1.7906
2021-11-12 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,070,272 -108,855 -3.42 347,585 5.56 1.6644
2021-08-12 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,179,127 -16,080 -0.50 329,262 23.21 1.5650
2021-05-13 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,195,207 371,210 13.14 267,247 3.73 1.3903
2021-02-12 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,823,997 -52,145 -1.81 257,633 12.22 1.4789
2020-11-13 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,876,142 25,860 0.91 229,574 16.55 1.5612
2020-08-13 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,850,282 1,913,728 204.34 196,983 11.51 1.4139
2020-05-14 2020-03-31 13F Edwards Lifesciences Corporati COM 28176E108 936,554 28,654 3.16 176,653 -16.60 1.5907
2020-02-13 2019-12-31 13F Edwards Lifesciences Corporati COM 28176E108 907,900 3,830 0.42 211,804 6.53 1.5484
2019-11-14 2019-09-30 13F Edwards Lifesciences Corporati COM 28176E108 904,070 80,835 9.82 198,814 30.73 1.6358
2019-08-13 2019-06-30 13F Edwards Lifesciences Corporati COM 28176E108 823,235 95,335 13.10 152,084 9.20 1.2765
2019-05-14 2019-03-31 13F Edwards Lifesciences Corporati COM 28176E108 727,900 57,390 8.56 139,269 35.60 1.2144
2019-02-13 2018-12-31 13F Edwards Lifesciences Corporati COM 28176E108 670,510 11,545 1.75 102,702 -10.48 1.0438
2018-11-13 2018-09-30 13F Edwards Lifesciences Corporati COM 28176E108 658,965 21,975 3.45 114,726 23.72 1.0175
2018-08-13 2018-06-30 13F Edwards Lifesciences Corporati COM 28176E108 636,990 72,965 12.94 92,727 17.83 0.8976
2018-05-14 2018-03-31 13F Edwards Lifesciences Corporati COM 28176E108 564,025 63,685 12.73 78,693 39.54 0.8507
2018-02-12 2017-12-31 13F Edwards Lifesciences Corporati COM 28176E108 500,340 500,340 56,393 0.6381
2016-11-14 2016-09-30 13F Edwards Lifesciences Corporati COM 28176E108 0 -159,390 -100.00 0 -100.00
2016-08-12 2016-06-30 13F Edwards Lifesciences Corporati COM 28176E108 159,390 -227,505 -58.80 15,896 -53.42 0.2739
2016-05-11 2016-03-31 13F Edwards Lifesciences Corporati COM 28176E108 386,895 -29,575 -7.10 34,128 3.75 0.6184
2016-02-12 2015-12-31 13F Edwards Lifesciences Corporati COM 28176E108 416,470 158,820 61.64 32,893 -10.20 0.5617
2015-11-13 2015-09-30 13F Edwards Lifesciences Corporati COM 28176E108 257,650 3,305 1.30 36,630 1.12 0.6397
2015-08-12 2015-06-30 13F Edwards Lifesciences Corporati COM 28176E108 254,345 29,990 13.37 36,226 13.34 0.5720
2015-11-12 2015-03-31 13F/A-1 Edwards Lifesciences Corporati COM 28176E108 224,355 -75,955 -25.29 31,962 -16.45 0.5452
2015-05-13 2015-03-31 13F Edwards Lifesciences Corporati COM 28176E108 224,355 31,962
2015-11-12 2014-12-31 13F/A-1 Edwards Lifesciences Corporati COM 28176E108 300,310 -99,340 -24.86 38,253 -6.30 0.6085
2015-02-11 2014-12-31 13F Edwards Lifesciences Corporati COM 28176E108 300,310 38,253
2015-11-12 2014-09-30 13F/A-1 Edwards Lifesciences Corporati COM 28176E108 399,650 -68,930 -14.71 40,824 1.49 0.7083
2014-11-14 2014-09-30 13F Edwards Lifesciences Corporati COM 28176E108 399,650 40,824
2014-08-13 2014-06-30 13F Edwards Lifesciences Corporati COM 28176E108 468,580 -101,045 -17.74 40,223 -4.80 0.6593
2014-05-13 2014-03-31 13F Edwards Lifesciences Corporati COM 28176E108 569,625 103,710 22.26 42,249 37.89 0.7268
2014-02-12 2013-12-31 13F Edwards Lifesciences Corporati COM 28176E108 465,915 151,025 47.96 30,639 39.74 0.5401
2013-11-12 2013-09-30 13F Edwards Lifesciences COM 28176E108 314,890 38,585 13.96 21,926 18.08 0.4163
2013-08-12 2013-06-30 13F Edwards Lifesciences COM 28176E108 276,305 276,305 18,568 0.3751
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.